• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Johnson & Johnson

J&J Vision, Menicon to collaborate on therapeutic contact lens

April 7, 2021 By Sean Whooley Leave a Comment

Johnson & Johnson (NYSE:JNJ) Vision announced today that it entered into a strategic collaboration with Menicon for contact lens development. J&J Vision and Menicon are partnering to bring forward a novel portfolio of products and services to manage the progression of myopia, sometimes known as “nearsightedness,” in children, according to a news release. Menicon is […]

Filed Under: Business/Financial News, Optical/Ophthalmic, Pediatrics Tagged With: Johnson & Johnson, Johnson & Johnson Vision

Emergent has reportedly had serious problems at Baltimore vaccine plant

April 6, 2021 By Chris Newmarker Leave a Comment

Emergent BioSolutions was not prepared to take on the mammoth task of churning out millions of COVID-19 vaccine doses to support U.S. efforts to end the pandemic, according to a report published today in The New York Times. Emergent was ill-equipped despite a $163 million federal contract to prepare the facility for high-volume production, according to the Times investigation, […]

Filed Under: Contract Manufacturing, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, COVID-19 vaccine, Emergent BioSolutions, Johnson & Johnson

Feds put J&J in charge of vaccine production at Emergent plant

April 5, 2021 By Sean Whooley Leave a Comment

Johnson & Johnson (NYSE:JNJ) announced that it assumed full responsibility for the production of its COVID-19 vaccine at the Emergent BioSolutions Bayview (Baltimore) facility. The company’s announcement comes days after news broke that a factory error made at that facility resulted in 15 million discarded COVID-19 vaccines. Get the full story at our sister site, […]

Filed Under: Contract Manufacturing, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Emergent BioSolutions, FDA, Johnson & Johnson

Whistleblower: FDA downplayed safety issues at Merck vaccine plant

April 2, 2021 By Brian Buntz Leave a Comment

A former FDA inspector accused the agency of downplaying safety problems at a Merck plant tapped to manufacture Johnson & Johnson’s COVID-19 vaccine. The whistleblower alleged that a 2018 inspection uncovered evidence that employees in the facility in Durham, N.C.engaged in a host of unsanitary practices. A letter to President Biden from the U.S. Office […]

Filed Under: Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, Johnson & Johnson, Merck

8 medical device companies that beat the COVID-19 pandemic and prospered

March 29, 2021 By Danielle Kirsh Leave a Comment

Some medical device businesses not only survived the COVID-19 pandemic but actually thrived — with many producing the medtech needed to fight the coronavirus’s spread. Medical Design & Outsourcing recently analyzed financials for 20 of the largest medical device businesses in the world. Not only was revenue only slightly down for the 20 during 2020, but it was […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Dental, Diagnostics, Endoscopic, Featured, Hospital Care, Imaging, Implants, Neuromodulation/Neurostimulation, Orthopedics, Replacement Heart Valves, Research & Development, Structural Heart Tagged With: 3m, Abbott, Alcon, Align Technology, Baxter, Big 100, Boston Scientific, coronavirus, COVID-19, danaher, Dentsply Sirona, Edwards Lifesciences, gehealthcare, Henry Schein, Intuitive Surgical, Johnson & Johnson, medline industries, Owens & Minor, Royal Philips, Smith+Nephew, Stryker, Teleflex, Zimmer Biomet

How big medtech fared during a year of COVID-19

March 25, 2021 By Danielle Kirsh

Despite numerous challenges, the medtech industry showed itself to be fairly recession-proof in 2020, according to a Medical Design & Outsourcing/MassDevice analysis of financials. Annual reports recently released by 20 of the world’s largest medical device companies showed only a slight dip in revenue during 2020 — a year in which medtech held the front lines against […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: 3m, Abbott, Alcon, Align Technology, Baxter, Boston Scientific, coronavirus, COVID-19, danaher, Dentsply Sirona, Edwards Lifesciences, GE Healthcare, Henry Schein, Intuitive Surgical, Johnson & Johnson, Medline Industries Inc., MedTech, Owens & Minor, Philips, Smith+Nephew, Stryker, Teleflex, Zimmer Biomet

J&J Vision wins Japanese approval for first drug-releasing contact lens

March 25, 2021 By Sean Whooley

Johnson & Johnson Vision announced that it received approval in Japan for its Acuvue Theravision lens with Ketotifen. The company touts the lens as the first and only vision-correcting contact lens that relieves allergic eye itch through drug delivery, according to a news release. Get the full story at our sister site, Drug Delivery Business […]

Filed Under: Drug-Device Combinations, Featured, Optical/Ophthalmic, Regulatory/Compliance Tagged With: Japanese Ministry of Health, Johnson & Johnson

Johnson & Johnson introduces new Acuvue Oasys multifocal lens

March 17, 2021 By Sean Whooley

Johnson & Johnson Vision (NYSE:JNJ) announced that it launched the Acuvue Oasys multifocal contact lenses with a pupil-optimized design. The new lens, available in the U.S. and in Canada, expands on the Acuvue Oasys portfolio to offer a new eye care option for patients with presbyopia, according to a news release. Acuvue Oasys multifocal lenses […]

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: Johnson & Johnson

MedTech 100 roundup: Industry rebounds from massive dip

March 15, 2021 By Sean Whooley

The medtech industry saw its largest fall in several months last week, but it has rebounded slightly after a couple of bad weeks. A strong start to 2021 hit a skid at the end of February and carried over into March, with MassDevice‘s MedTech 100 index hitting its lowest point on March 8 (102.16). It had […]

Filed Under: Business/Financial News, Featured, Funding Roundup, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Abbott, AdvaMed, Asensus Surgical, Boston Scientific, Cardinal Health, Johnson & Johnson, MedTech 100 Index, PerkinElmer Inc., Takeda Pharmaceuticals

Why emergency authorization of COVID-19 therapies could pose regulatory questions

March 11, 2021 By Brian Buntz

Few of the COVID-19 therapies in use in the U.S. have won full FDA approval. The widespread use of emergency use authorization may accelerate the distribution of disease-modifying agents and vaccines to patients, but it also could cause regulatory complications. “I’m nervous about the prospect of there never being a COVID vaccine that meets the […]

Filed Under: Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: COVID-19, FDA, Johnson & Johnson, Moderna, Pfizer, Regulatory, VRBPAC

Report: Biden to buy 100M additional doses of J&J COVID-19 vaccine

March 10, 2021 By Sean Whooley

President Joe Biden is reportedly set to announce plans to purchase an additional 100 million doses of Johnson & Johnson’s (NYSE:JNJ) COVID-19 vaccine. An NBC News report said that Biden is set to announce the purchase of the single-dose vaccines on Wednesday, according to two officials from his administration. Get the full story at our sister site, Drug Discovery […]

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, COVID-19 vaccine, Johnson & Johnson, Merck

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 8
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS